Neil McGregor

Neil R. McGregor, BDS, MDSc, PhD, is a senior researcher at the Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia and an Adjunct Professor at Victoria University, Melbourne, Australia. Trained as a periodontist, he developed an interest in ME/CFS research after treating ME/CFS patients with temporomandibular dysfunction syndrome. From 2003-2007, Dr. McGregor was a co-editor of the Journal of Chronic Fatigue Syndrome.

Dr. McGregor is a member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.

Books

 * 2006, Pediatric Chronic Fatigue Syndrome by Kenny de Meirleir, Neil McGregor, and Elke L.S. Van Hoof
 * 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by Christopher W. Armstrong, Neil R. McGregor, Henry L. Butt, and Paul R. Gooley

Notable studies

 * 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome - (Abstract)
 * 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome - (Abstract)
 * 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome - (Abstract)
 * 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome - (Abstract)
 * 2000, The Biochemistry of Chronic Pain and Fatigue - (Abstract)
 * 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome - (Abstract)
 * 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study - (Abstract)


 * 2001, A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome - (Full text)
 * 2002, Activity Limitations and Participation Restrictions in Patients with Chronic Fatigue Syndrome—Construction of a Disease Specific Questionnaire - (Abstract)
 * 2002, Possible Triggers and Mode of Onset of Chronic Fatigue Syndrome - (Abstract)
 * 2003, Monitoring a Hypothetical Channelopathy in Chronic Fatigue Syndrome: Preliminary Observations - (Abstract)
 * 2003, Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome - (Abstract)
 * 2003, Comparison of Activity Limitations/Participation Restrictions Among Fibromyalgia and Chronic Fatigue Syndrome Patients - (Abstract)
 * 2004, Membrane Damaging Toxins from Coagulase-Negative Staphylococcus Are Associated with Self-Reported Temporomandibular Disorder (TMD) in Patients with Chronic Fatigue Syndrome - (Abstract)
 * 2004, Association Between Oxidative Damage Markers and Self-Reported Temporomandibular Dysfunction Symptoms in Patients with Chronic Fatigue Syndrome - (Abstract)
 * 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway - (Full Text)
 * 2007, Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome - (Abstract)
 * 2009, Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome - (Full text)
 * 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome - (Abstract)
 * 2014, Metabolism in chronic fatigue syndrome - (Abstract)
 * 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients - (Abstract)
 * 2016, Widespread pain and altered renal function in ME/CFS patients - (Abstract)
 * 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome - (Abstract)
 * 2019, Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases - (Full text)

Talks and interviews

 * 12 Aug 2017, Community Symposium on the Molecular Basis of ME/CFS - 2017: Speech title - Genome-wide analysis & metabolome changes in ME/CFS
 * 14 Mar 2019, An Omic Analysis of ME/CFS – an Assessment of Potential Mechanisms given at the International Research Symposium, Geelong, Australia, sponsored by Emerge Australia

Online presence

 * LinkedIn
 * ResearchGate

Learn more

 * Meet the Scientists: Dr Neil McGregor